Medicine regulatory framework of nepal: ways forward

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: POUDEL, Bhupendra (Department of Drug Administration (DDA), Inspection Division, Kathmandu, Nepal)
  • Co-author(s): Bhupendra Kumar Poudel: Department of Drug Administration (DDA), Kathmandu, Nepal;Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8675, Japan
    Itsuko Ishii: Division of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan
  • Abstract:


    Field study and personal communication among stakeholders of medicine was done and current challenges studied.


    NHP has ushered need of revision of National Medicines Policy & Drugs Act and hence, are under revision: incorporating medical devices, surgicals and cosmetic products. Further, Ministry of Health has now initiated 


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login